Comparison of Clinical Outcomes Between GentleWave® and Biolase®
NCT: NCT05555043 · COMPLETED
Brief Summary
Introduction: In the US, 15 million root canal treatments (RCTs) are carried out annually. Success rates decrease with conventional chemo-mechanical root canal preparation techniques used on teeth with periapical radiolucencies associated with bacterial presence. New irrigation modalities, such as the GentleWave® System (GWS) and Waterlase iPlus® (WL), have been developed to overcome limitations and improve RCT success rates. Hypotheses: (1) GWS and WL provide superior clinical outcomes compared to conventional RCT using passive ultrasonic activation (PUI). (2) GWS and WL are acceptable treatment modalities for clinicians and patients. Aims: (1) Estimate probability of success of GWS, WL, and conventional RCT with PUI. (2) Evaluate clinician and patient experiences of the different techniques.
Frequently Asked Questions
What is Comparison of Clinical Outcomes Between GentleWave® and Biolase®?
Comparison of Clinical Outcomes Between GentleWave® and Biolase® is a clinical trial registered under NCT05555043. Current status: COMPLETED.
What is the status of NCT05555043?
The current status of NCT05555043 (Comparison of Clinical Outcomes Between GentleWave® and Biolase®) is: COMPLETED.
When did Comparison of Clinical Outcomes Between GentleWave® and Biolase® start?
Comparison of Clinical Outcomes Between GentleWave® and Biolase® started on 2022-11-08.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.